Small Animal Imaging (In-Vivo) Market Poised for 12.312% % Growth, Set to Hit $7.74 Billion by 2029

Which drivers are expected to have the greatest impact on the over the small animal imaging (in-vivo) market's growth?
The surge in healthcare expenditure is predicted to fuel the expansion of the small animal imaging (in vivo) market. Healthcare expenditure encompasses the total healthcare costs, including public and private spending, in relation to GDP. A rising investment in healthcare and an elevated awareness of health issues foster the self-care management strategy, which utilises PET equipment for small animal imaging techniques. For example, the Office for National Statistics, a UK-based statistical bureau, revealed that the UK's healthcare expenditure rose by 5.6% nominally in 2023, while long-term health and social care expenses grew by 2.8% in real terms in 2022. Consequently, the escalating financial commitment to the healthcare sector is steering the small animal imaging (in-vivo) market's growth.

Get Your Small Animal Imaging (In-Vivo) Market Report Here:
https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

What is the future CAGR of the small animal imaging (in-vivo) market, and how will it impact industry expansion?
In recent years, there has been a significant increase in the size of the small animal imaging (in-vivo) market. The market is predicted to expand from $2.84 billion in 2024 to reach $3.17 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.8%. The substantial growth observed in the historic period can be credited to factors such as preclinical research, drug development, the proliferation of the pharmaceutical and biotechnology industries, advancements in translational research, disease modeling and pathophysiology studies, along with academic and government contributions towards research.

In the coming years, the market size for small animal imaging (in-vivo) is projected to experience swift expansion. The market value is expected to rise to $5.05 billion in 2029, with a compound annual growth rate (CAGR) of 12.3%. Forecasted growth can be linked to advancements in imaging probes and tracers, the broadening of preclinical CROs (contract research organizations), the adoption of AI in image scrutiny, the advent of advanced multimodal imaging systems, and the utilization of 3D and high-definition imaging for small animals. The surge in research concerning rare and orphan diseases also contributes to this growth. Noteworthy trends for the forecast period encompass molecular and functional imaging in small animals, contemporaneous and longitudinal in-vivo imaging, the combination of imaging modalities for multifaceted information, imaging for genetics research on CRISPR-modified animals, the use of AI in phenotyping and biomarker location, and imaging applied to neurodegenerative diseases and neuroscience studies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What are the most significant trends transforming the small animal imaging (in-vivo) market today?
The rising trend of technological enhancement is notable in the small animal imaging (in-vivo) market. The focus of key market players, such as PerkinElmer, Inc., is on technological progression to consolidate their market stance. For example, this US-based company, involved in diagnostics, life science research, and imaging, launched the technologically sophisticated Vega imaging system in April 2022. This automated technology utilizes dual automated transducers, making it user-friendly and producing more reliable results, facilitating the detailed visual representation of disease pathophysiology.

Which key market segments comprise the small animal imaging (in-vivo) market and drive its revenue growth?
The small animal imaging (In-Vivo) market covered in this report is segmented -

1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Subsegments:
1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents
2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems
3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers
4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7303

What regions are at the forefront of small animal imaging (in-vivo) market expansion?
North America was the largest region in the small animal imaging (in-vivo) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the leading players fueling growth in the small animal imaging (in-vivo) market?
Major companies operating in the small animal imaging (In-Vivo) market include Bruker Corporation, PerkinElmer Inc., Miltenyi Biotec GmbH, Aspect Imaging Ltd., Mediso Ltd., Siemens AG, Life Technologies Corporation, Promega Corporation, Berthold Technologies GmbH and Co. KG, Spectral Instruments Imaging LLC, Agilent Technologies Inc., Bioscan Inc., Gamma Medica-Ideas Inc., Genovis AB, LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

What Is Covered In The Small Animal Imaging (In-Vivo) Global Market Report?

•Market Size Forecast: Examine the small animal imaging (in-vivo) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the small animal imaging (in-vivo) market for a structured understanding.
•Key Players Overview: Analyze major players in the small animal imaging (in-vivo) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the small animal imaging (in-vivo) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the small animal imaging (in-vivo) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the small animal imaging (in-vivo) market.
•Industry Challenges: Identify potential risks and obstacles affecting the small animal imaging (in-vivo) market.
•Competitive Landscape: Review strategic developments in the small animal imaging (in-vivo) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.